Radiology, Vol 197, 603-608, Copyright © 1995 by Radiological Society of North America

ARTICLES

Change in endometrial thickness in postmenopausal women undergoing hormone replacement therapy

D Levine, BB Gosink and LA Johnson
Department of Radiology, Beth Israel Hospital, Boston, MA 02215, USA.

PURPOSE: To evaluate the effect over time of hormone replacement on endometrial thickness in asymptomatic postmenopausal women. MATERIALS AND METHODS: Endometrial thickness was measured on 644 sonograms of 120 postmenopausal volunteers receiving no hormones or one of three hormone regimens. Each subject underwent ultrasound (US) two to nine times. In addition, eight women using sequential hormones underwent US seven to 20 times over 2 months. The greatest endometrial thickness and change in endometrial thickness over time were evaluated. RESULTS: Endometrial thickness was statistically significantly greater in women using sequential hormones (8 mm) compared with that in control subjects (5 mm). Change in endometrial thickness (> 3-mm difference) was seen in 23 of 40 women using sequential hormones compared with six of 61 controls. Women using sequential hormones demonstrated maximum endometrial thickness on days 13-23 of the cycle. CONCLUSION: Women using sequential hormones show greater endometrial thickness than that in controls and show the most variation in measurements. They should undergo US either early or late in the hormone cycle to evaluate the endometrium at its thinnest.

This article has been cited by other articles:

				A. S.Y. Sit, F. Modugno, L. M. Hill, J. Martin, and J. L. Weissfeld Transvaginal Ultrasound Measurement of Endometrial Thickness as a Biomarker for Estrogen Exposure Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1459 - 1465. [Abstract] [Full Text] [PDF]

				H. Lerman, U. Metser, D. Grisaru, A. Fishman, G. Lievshitz, and E. Even-Sapir Normal and Abnormal 18F-FDG Endometrial and Ovarian Uptake in Pre- and Postmenopausal Patients: Assessment by PET/CT J. Nucl. Med., February 1, 2004; 45(2): 266 - 271. [Abstract] [Full Text] [PDF]

				P. L. Williams, S. L. Laifer-Narin, and N. Ragavendra US of Abnormal Uterine Bleeding RadioGraphics, May 1, 2003; 23(3): 703 - 718. [Abstract] [Full Text] [PDF]

				S. Laifer-Narin, N. Ragavendra, E. K. Parmenter, and E. G. Grant False-Normal Appearance of the Endometrium on Conventional Transvaginal Sonography: Comparison with Saline Hysterosonography Am. J. Roentgenol., January 1, 2002; 178(1): 129 - 133. [Abstract] [Full Text] [PDF]

				K. M. Nalaboff, J. S. Pellerito, and E. Ben-Levi Imaging the Endometrium: Disease and Normal Variants RadioGraphics, November 1, 2001; 21(6): 1409 - 1424. [Abstract] [Full Text] [PDF]

				S. M. Ascher, I. Imaoka, and J. M. Lage Tamoxifen-induced Uterine Abnormalities: The Role of Imaging1 Radiology, January 1, 2000; 214(1): 29 - 38. [Abstract] [Full Text]

				J. R. Jorizzo, G. J. Riccio, M. Y. M. Chen, and J. J. Carr Sonohysterography: The Next Step in the Evaluation of the Abnormal Endometrium RadioGraphics, October 1, 1999; 19(90001): 117 - 130. [Abstract] [Full Text]

				A. C. Fleischer Optimizing the Accuracy of Transvaginal Ultrasonography of the Endometrium N. Engl. J. Med., December 18, 1997; 337(25): 1839 - 1840. [Full Text]